Antibodies to Enteroviruses in Cerebrospinal Fluid of Patients with Acute Flaccid Myelitis

ABSTRACT Acute flaccid myelitis (AFM) has caused motor paralysis in >560 children in the United States since 2014. The temporal association of enterovirus (EV) outbreaks with increases in AFM cases and reports of fever, respiratory, or gastrointestinal illness prior to AFM in >90% of cases sug...

Full description

Bibliographic Details
Main Authors: Nischay Mishra, Terry Fei Fan Ng, Rachel L. Marine, Komal Jain, James Ng, Riddhi Thakkar, Adrian Caciula, Adam Price, Joel A. Garcia, Jane C. Burns, Kiran T. Thakur, Kimbell L. Hetzler, Janell A. Routh, Jennifer L. Konopka-Anstadt, W. Allan Nix, Rafal Tokarz, Thomas Briese, M. Steven Oberste, W. Ian Lipkin
Format: Article
Language:English
Published: American Society for Microbiology 2019-08-01
Series:mBio
Subjects:
Online Access:https://journals.asm.org/doi/10.1128/mBio.01903-19
_version_ 1818858406139658240
author Nischay Mishra
Terry Fei Fan Ng
Rachel L. Marine
Komal Jain
James Ng
Riddhi Thakkar
Adrian Caciula
Adam Price
Joel A. Garcia
Jane C. Burns
Kiran T. Thakur
Kimbell L. Hetzler
Janell A. Routh
Jennifer L. Konopka-Anstadt
W. Allan Nix
Rafal Tokarz
Thomas Briese
M. Steven Oberste
W. Ian Lipkin
author_facet Nischay Mishra
Terry Fei Fan Ng
Rachel L. Marine
Komal Jain
James Ng
Riddhi Thakkar
Adrian Caciula
Adam Price
Joel A. Garcia
Jane C. Burns
Kiran T. Thakur
Kimbell L. Hetzler
Janell A. Routh
Jennifer L. Konopka-Anstadt
W. Allan Nix
Rafal Tokarz
Thomas Briese
M. Steven Oberste
W. Ian Lipkin
author_sort Nischay Mishra
collection DOAJ
description ABSTRACT Acute flaccid myelitis (AFM) has caused motor paralysis in >560 children in the United States since 2014. The temporal association of enterovirus (EV) outbreaks with increases in AFM cases and reports of fever, respiratory, or gastrointestinal illness prior to AFM in >90% of cases suggest a role for infectious agents. Cerebrospinal fluid (CSF) from 14 AFM and 5 non-AFM patients with central nervous system (CNS) diseases in 2018 were investigated by viral-capture high-throughput sequencing (VirCapSeq-VERT system). These CSF and serum samples, as well as multiple controls, were tested for antibodies to human EVs using peptide microarrays. EV RNA was confirmed in CSF from only 1 adult AFM case and 1 non-AFM case. In contrast, antibodies to EV peptides were present in CSF of 11 of 14 AFM patients (79%), significantly higher than controls, including non-AFM patients (1/5 [20%]), children with Kawasaki disease (0/10), and adults with non-AFM CNS diseases (2/11 [18%]) (P = 0.023, 0.0001, and 0.0028, respectively). Six of 14 CSF samples (43%) and 8 of 11 sera (73%) from AFM patients were immunoreactive to an EV-D68-specific peptide, whereas the three control groups were not immunoreactive in either CSF (0/5, 0/10, and 0/11; P = 0.008, 0.0003, and 0.035, respectively) or sera (0/2, 0/8, and 0/5; P = 0.139, 0.002, and 0.009, respectively). IMPORTANCE The presence in cerebrospinal fluid of antibodies to EV peptides at higher levels than non-AFM controls supports the plausibility of a link between EV infection and AFM that warrants further investigation and has the potential to lead to strategies for diagnosis and prevention of disease.
first_indexed 2024-12-19T08:55:47Z
format Article
id doaj.art-aac3bce73c744aba9b817e8d6ed19651
institution Directory Open Access Journal
issn 2150-7511
language English
last_indexed 2024-12-19T08:55:47Z
publishDate 2019-08-01
publisher American Society for Microbiology
record_format Article
series mBio
spelling doaj.art-aac3bce73c744aba9b817e8d6ed196512022-12-21T20:28:37ZengAmerican Society for MicrobiologymBio2150-75112019-08-0110410.1128/mBio.01903-19Antibodies to Enteroviruses in Cerebrospinal Fluid of Patients with Acute Flaccid MyelitisNischay Mishra0Terry Fei Fan Ng1Rachel L. Marine2Komal Jain3James Ng4Riddhi Thakkar5Adrian Caciula6Adam Price7Joel A. Garcia8Jane C. Burns9Kiran T. Thakur10Kimbell L. Hetzler11Janell A. Routh12Jennifer L. Konopka-Anstadt13W. Allan Nix14Rafal Tokarz15Thomas Briese16M. Steven Oberste17W. Ian Lipkin18Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USADivision of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USADivision of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USACenter for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USACenter for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USACenter for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USACenter for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USACenter for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USACenter for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USADepartment of Pediatrics, University of California San Diego School of Medicine, La Jolla, California, USADivision of Critical Care and Hospitalist Neurology, Department of Neurology, Columbia Irving University Medical Center, New York, New York, USADivision of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USADivision of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USADivision of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USADivision of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USACenter for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USACenter for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USADivision of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USACenter for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USAABSTRACT Acute flaccid myelitis (AFM) has caused motor paralysis in >560 children in the United States since 2014. The temporal association of enterovirus (EV) outbreaks with increases in AFM cases and reports of fever, respiratory, or gastrointestinal illness prior to AFM in >90% of cases suggest a role for infectious agents. Cerebrospinal fluid (CSF) from 14 AFM and 5 non-AFM patients with central nervous system (CNS) diseases in 2018 were investigated by viral-capture high-throughput sequencing (VirCapSeq-VERT system). These CSF and serum samples, as well as multiple controls, were tested for antibodies to human EVs using peptide microarrays. EV RNA was confirmed in CSF from only 1 adult AFM case and 1 non-AFM case. In contrast, antibodies to EV peptides were present in CSF of 11 of 14 AFM patients (79%), significantly higher than controls, including non-AFM patients (1/5 [20%]), children with Kawasaki disease (0/10), and adults with non-AFM CNS diseases (2/11 [18%]) (P = 0.023, 0.0001, and 0.0028, respectively). Six of 14 CSF samples (43%) and 8 of 11 sera (73%) from AFM patients were immunoreactive to an EV-D68-specific peptide, whereas the three control groups were not immunoreactive in either CSF (0/5, 0/10, and 0/11; P = 0.008, 0.0003, and 0.035, respectively) or sera (0/2, 0/8, and 0/5; P = 0.139, 0.002, and 0.009, respectively). IMPORTANCE The presence in cerebrospinal fluid of antibodies to EV peptides at higher levels than non-AFM controls supports the plausibility of a link between EV infection and AFM that warrants further investigation and has the potential to lead to strategies for diagnosis and prevention of disease.https://journals.asm.org/doi/10.1128/mBio.01903-19VirCapSeq-VERTacute flaccid myelitisantibodiesenterovirusenterovirus D-68peptide array
spellingShingle Nischay Mishra
Terry Fei Fan Ng
Rachel L. Marine
Komal Jain
James Ng
Riddhi Thakkar
Adrian Caciula
Adam Price
Joel A. Garcia
Jane C. Burns
Kiran T. Thakur
Kimbell L. Hetzler
Janell A. Routh
Jennifer L. Konopka-Anstadt
W. Allan Nix
Rafal Tokarz
Thomas Briese
M. Steven Oberste
W. Ian Lipkin
Antibodies to Enteroviruses in Cerebrospinal Fluid of Patients with Acute Flaccid Myelitis
mBio
VirCapSeq-VERT
acute flaccid myelitis
antibodies
enterovirus
enterovirus D-68
peptide array
title Antibodies to Enteroviruses in Cerebrospinal Fluid of Patients with Acute Flaccid Myelitis
title_full Antibodies to Enteroviruses in Cerebrospinal Fluid of Patients with Acute Flaccid Myelitis
title_fullStr Antibodies to Enteroviruses in Cerebrospinal Fluid of Patients with Acute Flaccid Myelitis
title_full_unstemmed Antibodies to Enteroviruses in Cerebrospinal Fluid of Patients with Acute Flaccid Myelitis
title_short Antibodies to Enteroviruses in Cerebrospinal Fluid of Patients with Acute Flaccid Myelitis
title_sort antibodies to enteroviruses in cerebrospinal fluid of patients with acute flaccid myelitis
topic VirCapSeq-VERT
acute flaccid myelitis
antibodies
enterovirus
enterovirus D-68
peptide array
url https://journals.asm.org/doi/10.1128/mBio.01903-19
work_keys_str_mv AT nischaymishra antibodiestoenterovirusesincerebrospinalfluidofpatientswithacuteflaccidmyelitis
AT terryfeifanng antibodiestoenterovirusesincerebrospinalfluidofpatientswithacuteflaccidmyelitis
AT rachellmarine antibodiestoenterovirusesincerebrospinalfluidofpatientswithacuteflaccidmyelitis
AT komaljain antibodiestoenterovirusesincerebrospinalfluidofpatientswithacuteflaccidmyelitis
AT jamesng antibodiestoenterovirusesincerebrospinalfluidofpatientswithacuteflaccidmyelitis
AT riddhithakkar antibodiestoenterovirusesincerebrospinalfluidofpatientswithacuteflaccidmyelitis
AT adriancaciula antibodiestoenterovirusesincerebrospinalfluidofpatientswithacuteflaccidmyelitis
AT adamprice antibodiestoenterovirusesincerebrospinalfluidofpatientswithacuteflaccidmyelitis
AT joelagarcia antibodiestoenterovirusesincerebrospinalfluidofpatientswithacuteflaccidmyelitis
AT janecburns antibodiestoenterovirusesincerebrospinalfluidofpatientswithacuteflaccidmyelitis
AT kirantthakur antibodiestoenterovirusesincerebrospinalfluidofpatientswithacuteflaccidmyelitis
AT kimbelllhetzler antibodiestoenterovirusesincerebrospinalfluidofpatientswithacuteflaccidmyelitis
AT janellarouth antibodiestoenterovirusesincerebrospinalfluidofpatientswithacuteflaccidmyelitis
AT jenniferlkonopkaanstadt antibodiestoenterovirusesincerebrospinalfluidofpatientswithacuteflaccidmyelitis
AT wallannix antibodiestoenterovirusesincerebrospinalfluidofpatientswithacuteflaccidmyelitis
AT rafaltokarz antibodiestoenterovirusesincerebrospinalfluidofpatientswithacuteflaccidmyelitis
AT thomasbriese antibodiestoenterovirusesincerebrospinalfluidofpatientswithacuteflaccidmyelitis
AT mstevenoberste antibodiestoenterovirusesincerebrospinalfluidofpatientswithacuteflaccidmyelitis
AT wianlipkin antibodiestoenterovirusesincerebrospinalfluidofpatientswithacuteflaccidmyelitis